Imaging evaluation of demyelinating processes of the central nervous system

Postgraduate Medical Journal

Volumn 86, Issue 1014, 2010, Pages 218-229

  Smith, Alice Boyd ^a,b   Smirniotopoulos, James G ^a,b  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GADOLINIUM; METHOTREXATE;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ANAMNESIS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CYANOCOBALAMIN DEFICIENCY; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LEUKOENCEPHALOPATHY; MARCHIAFAVA BIGNAMI DISEASE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSMOTIC DEMYELINATION; PHYSICAL EXAMINATION; RADIATION EXPOSURE; REVIEW; TUMEFACTIVE DEMYELINATING LESION; WERNICKE ENCEPHALOPATHY; ENCEPHALOMYELITIS; PATHOLOGY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;

CENTRAL NERVOUS SYSTEM DISEASES; DEMYELINATING DISEASES; ENCEPHALOMYELITIS; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; TOMOGRAPHY, X-RAY COMPUTED; WERNICKE ENCEPHALOPATHY;

EID: 77950835376     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2009.087452     Document Type: Review

References (51)

1. Vercellino M, Masera S, Lorenzatti M, et al. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol 2009;68:489-502.
2. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-85. (Pubitemid 28065253)
3. Ciccarelli O, Giugni E, Paolillo A, et al. Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis. Eur J Neurol 1999;6:455-9. (Pubitemid 29371143)
4. Minagar A, Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler 2003;9:540-9. (Pubitemid 37479401)
5. Rovira A, Pericot I, Alonso J, et al. Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report. AJNR Am J Neuroradiol 2002;23:989-94. (Pubitemid 34663446)
6. Courtney AM, Treadway K, Remington G, et al. Multiple sclerosis. Med Clin North Am 2009:93:451-76, ixex.
7. Weiner HL. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol 2009;65:239-48.
8. Debouverie M, Pittion-Vouyovitch S, Louis S, et al. Natural history of multiple sclerosis in a population-based cohort. Eur J Neurol 2008;15:916-21.
9. Polliack ML, Barak Y, Achiron A. Late-onset multiple sclerosis. J Am Geriatr Soc 2001;49:168-71. (Pubitemid 32207226)
10. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-6. (Pubitemid 41746873)
11. McDonald WI, Compstona A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7.
12. Link H, Huang YM. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol 2006;180:17-28. (Pubitemid 44692326)
13. Mushlin AI, Detsky AS, Phelps CE. The accuracy of magnetic resonance imaging in patients with suspected multiple sclerosis. The Rochester-Toronto Magnetic Resonance Imaging Study Group. JAMA 1993:269:3146-51. (Pubitemid 23171713)
14. Gean-Marton AD, Vezina LG, Marton KI, et al. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. Radiology 1991;80:215-21.
15. Love S. Demyelinating diseases. J Clin Pathol 2006;59:1151-9. (Pubitemid 44787134)
16. Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962;25:315-20.
17. Lisanti CJ, Asbach P, Bradley WG. The ependymal "Dot-Dash" sign: an MR imaging finding of early multiple sclerosis. AJNR Am J Neuroradiol 2005;26:2033-6.
18. Allen IV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979;41:81-91.
19. Edwards MK, Farlow MR, Stevens JC. Cranial MR in spinal cord MS: diagnosing patients with isolated spinal cord symptoms. AJNR Am J Neuroradiol 1986;7:1003-5.
20. Thorpe JW, Kidd D, Moseley IF, et al. Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 1996;119:709-14. (Pubitemid 26237170)
21. Adams RD, Kubik CS. The morbid anatomy of the demyelinative disease. Am J Med 1952;12:510-46.
22. Rocca MA, Mastronardo G, Horsfield MA, et al. Comparison of three MR sequences for the detection of cervical cord lesions in patients with multiple sclerosis. AJNR Am J Neuroradiol 1999;20:1710-16. (Pubitemid 29498627)
23. Karaarslan E, Altintas A, Senol U, et al. Balo's concentric sclerosis: clinical and radiologic features of five cases. AJNR Am J Neuroradiol 2001;22:1362-7. (Pubitemid 32734812)
24. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202:473-7.
25. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-12.
26. Yu CS, Lin FC, Li KC, et al. Diffusion tensor imaging in the assessment of normalappearing brain tissue damage in relapsing neuromyelitis optica. AJNR Am J Neuroradiol 2006;27:1009-15.
27. Dagher AP, Smirniotopoulos J. Tumefactive demyelinating lesions. Neuroradiology 1996;38:560-5. (Pubitemid 26288246)
28. Hunter SB, Ballinger WE, Rubin JJ. Multiple sclerosis mimicking primary brain tumor. Arch Pathol Lab Med 1987;111:464-8. (Pubitemid 17073568)
29. Zagzag D, Miller DC, Kleinman GM, et al. Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosis. Am J Surg Pathol 1993;17:537-45. (Pubitemid 23152591)
30. Malhotra HS, Jain KK, Agarwal A, et al. Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy. Mult Scler 2009;15:193-203.
31. Cha S, Pierce S, Knopp EA, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2001;22:1109-16. (Pubitemid 32587424)
32. Kepes JJ. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 1993;33:18-27.
33. Hart MN, Earle KM. Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases. J Neurol Neurosurg Psychiatry 1975;38:585-91.
34. Saito H, Endo M, Takase S, et al. Acute disseminated encephalomyelitis after influenza vaccination. Arch Neurol 1980;37:564-6. (Pubitemid 10059168)
35. Tenembaum S, Chitnis T, Ness J, et al. Acute disseminated encephalomyelitis. Neurology 2007;68:S23-36. (Pubitemid 46626003)
36. Shoji H, Kusuhara T, Honda Y, et al. Relapsing acute disseminated encephalomyelitis associated with chronic Epstein-Barr virus infection: MRI findings. Neuroradiology 1992;34:340-2.
37. Dale RC, de Sousa C, Chong WK, et al. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;123:2407-22.
38. McArthur JC, Sacktor N, Selnes O. Human immunodeficiency virus-associated dementia. Semin Neurol 1999;19:129-50. (Pubitemid 29477586)
39. Bouwman FH, Skolasky RL, Hes D, et al. Variable progression of HIV-associated dementia. Neurology 1998;50:1814-20. (Pubitemid 28283257)
40. Dore GJ, McDonald A, Li Y, et al. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003;17:1539-45. (Pubitemid 36900555)
41. Smith AB, Smirniotopoulos JG, Rushing EJ. From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. Radiographics 2008;28:2033-58.
42. Scaravilli F, Bazille C, Gray F. Neuropathologic contributions to understanding AIDS and the central nervous system. Brain Pathol 2007;17:97-208. (Pubitemid 46466132)
43. Filippi CG, Ulug AM, Ryan E, et al. Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. AJNR Am J Neuroradiol 2001;22:277-83. (Pubitemid 32163456)
44. Thurnher MM, Schindler EG, Thurnher SA, et al. Highly active antiretroviral therapy for patients with AIDS dementia complex: effect on MR imaging findings and clinical course. AJNR Am J Neuroradiol 2000;21:670-8.
45. Hogan TF, Padgett BL, Walker DL, et al. Rapid detection and identification of JC virus and BK virus in human urine by using immunofluorescence microscopy. J Clin Microbiol 1980;11:178-83.
46. McGuire D, Barhite S, Hollander H, et al. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann Neurol 1995;37:395-9.
47. Abbott R, Silber E, Felber J, et al. Osmotic demyelination syndrome. BMJ 2005;31:829-30.
48. Ruzek KA, Campeau NG, Miller GM. Early diagnosis of central pontine myelinolysis with diffusion-weighted imaging. AJNR Am J Neuroradiol 2004;25:210-3.
49. Zuccoli G, Gallucci M, Capellades J, et al. Wernicke encephalopathy: MR findings at clinical presentation in twenty-six alcoholic and nonalcoholic patients. AJNR Am J Neuroradiol 2007;28:1328-31. (Pubitemid 47309667)
50. Fisher MJ, Khademian ZP, Simon EM, et al. Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children. AJNR Am J Neuroradiol 2005;26:1686-9.
51. Keogh CF, Andrews GT, Spacey SD, et al. Neuroimaging features of heroin inhalation toxicity: "Chasing the dragon." Am J Roentgenol 2003;180:847-50.